Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mendes

Showing results (321-330 of 473) with videos related to

Pageof 48
Sort By:
Jac-Antimicrobial Resistance|October 24, 2025
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinationsHelio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012Rodrigo E Mendes, Rosalind C Hollingsworth, Andrew Costello, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2020
Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophiliaM Biagi, A Vialichka, M Jurkovic, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized IsolatesRodrigo E Mendes, Mariana Castanheira, Leanne Gasink, et al.
Journal of Veterinary Pharmacology and Therapeutics|February 1, 1997
Changes in taurine levels in response to repeated administration of the beta 2-agonist salbutamol in lambsM L Bastos, F Carvalho, F Remião, et al.
Jac-Antimicrobial Resistance|October 21, 2021
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19)Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 20, 2001
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance ProgramH S Sader, A C Gales, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2025
Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023)Michael D Huband, Kelley A Fedler, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2018
ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countriesRodrigo E Mendes, Lalitagauri Deshpande, Jennifer M Streit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2024
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards InstituteNavaneeth Narayanan, Amy J Mathers, Eric Wenzler, et al.
Pageof 48

Showing results (321-330 of 473) with videos related to

Sort By:
Pageof 48
Jac-Antimicrobial Resistance|October 24, 2025
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinationsHelio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012Rodrigo E Mendes, Rosalind C Hollingsworth, Andrew Costello, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2020
Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophiliaM Biagi, A Vialichka, M Jurkovic, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized IsolatesRodrigo E Mendes, Mariana Castanheira, Leanne Gasink, et al.
Journal of Veterinary Pharmacology and Therapeutics|February 1, 1997
Changes in taurine levels in response to repeated administration of the beta 2-agonist salbutamol in lambsM L Bastos, F Carvalho, F Remião, et al.
Jac-Antimicrobial Resistance|October 21, 2021
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19)Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 20, 2001
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance ProgramH S Sader, A C Gales, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2025
Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023)Michael D Huband, Kelley A Fedler, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2018
ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countriesRodrigo E Mendes, Lalitagauri Deshpande, Jennifer M Streit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2024
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards InstituteNavaneeth Narayanan, Amy J Mathers, Eric Wenzler, et al.
Pageof 48